What does Electra Therapeutics, Inc. do?
Electra Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company develops therapies that targets signal regulatory proteins for the treatment of novel targets for treatment of immune-mediated diseases and cancer. Its lead product candidate is ipsoprubart, that targets signal regulatory protein on…
What is Electra Therapeutics, Inc.'s P/E and P/B ratio?
Electra Therapeutics, Inc. has a P/E ratio of -3.5 and a P/B ratio of -21.69.
What is Electra Therapeutics, Inc.'s debt-to-equity ratio?
Electra Therapeutics, Inc. has a debt-to-equity ratio of 0.02.
How much does Electra Therapeutics, Inc. owe compared with what it owns?
Electra Therapeutics, Inc. owes $1.25 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Electra Therapeutics, Inc.'s Positivity rank?
Electra Therapeutics, Inc. is ranked #6,608 of 6,775 companies globally and #3,847 of 4,000 in United States on PositoAI, with a Positivity Score of -29,798.
Does Electra Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Electra Therapeutics, Inc..
Where can I read the latest news about Electra Therapeutics, Inc.?
Recent headlines about Electra Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Electra Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Electra Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.